Inventor · disambiguated record
Fengtian Xue
Also filed as: XUE FENGTIAN
19 granted patents·6 pending applications·71 citations·filing 2010–2023
93Inventor score
Top patents by PatentIndex Score
25 records- 0190US10882841B2Wnt signaling pathway inhibitors for treatments of diseaseUNIV MARYLAND·Filed 2017·Granted Jan 5, 2021·6 cites·28 claims
- 0290US9758507B2Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitorsUNIV NORTHWESTERN·Filed 2015·Granted Sep 12, 2017·4 cites·8 claims
- 0389US9765055B2Intramolecular hydrogen-bonded nitric oxide synthase inhibitorsUNIV NORTHWESTERN·Filed 2015·Granted Sep 19, 2017·4 cites·4 claims
- 0489US9212161B2Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitorsUNIV NORTHWESTERN·Filed 2014·Granted Dec 15, 2015·4 cites·7 claims
- 0588US11655233B2WNT signaling pathway inhibitors for treatments of diseaseUNIV MARYLAND·Filed 2020·Granted May 23, 2023·2 cites·6 claims
- 0688US8932842B2Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibitionUNIV NORTHWESTERN·Filed 2012·Granted Jan 13, 2015·8 cites·20 claims
- 0788US8697879B2Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitorsSILVERMAN RICHARD B·Filed 2011·Granted Apr 15, 2014·4 cites·7 claims
- 0887US8829187B1Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthaseUNIV NORTHWESTERN·Filed 2013·Granted Sep 9, 2014·4 cites·24 claims
- 0987US8278084B2Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibitionSILVERMAN RICHARD B·Filed 2010·Granted Oct 2, 2012·10 cites·20 claims
- 1086US9090589B2Specific nNOS inhibitors for the therapy and prevention of human melanomaUNIV NORTHWESTERN·Filed 2014·Granted Jul 28, 2015·4 cites·15 claims
- 1186US8299100B2Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeabilitySILVERMAN RICHARD B·Filed 2010·Granted Oct 30, 2012·10 cites·22 claims
- 1283US8389731B2Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthaseSILVERMAN RICHARD B·Filed 2010·Granted Mar 5, 2013·3 cites·5 claims
- 1382US8642282B2Inhibitors of nitric oxide synthase for treatment of melanomaMEYSKENS JR FRANK L·Filed 2012·Granted Feb 4, 2014·5 cites·14 claims
- 1477US12378220B2WNT signaling pathway inhibitors for treatments of diseaseUNIV MARYLAND·Filed 2023·Granted Aug 5, 2025·0 cites·9 claims
- 1577US10227320B2Compounds for treating parasitic infectionsUNIV MARYLAND·Filed 2016·Granted Mar 12, 2019·2 cites·2 claims
- 1671US9943506B2BCL6 inhibitors as anticancer agentsUNIV CORNELL·Filed 2014·Granted Apr 17, 2018·1 cites·7 claims
- 1762US2025042873A1Compositions and methods for treating proteotoxicity-associated diseasesUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1859US2025313532A1Aldh2 inhibitors and methods of use thereofUNIV MARYLAND·Filed 2023·Application pending·0 cites
- 1956US10662168B2Compounds for treating parasitic infectionsUNIV MARYLAND·Filed 2019·Granted May 26, 2020·0 cites·12 claims
- 2053US2024279201A1Dual wnt signaling pathway inhibitors and ampk activators for treatments of diseaseXUE FENGTIAN·Filed 2022·Application pending·0 cites
- 2146US9701627B2LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disordersUNIV MARYLAND·Filed 2015·Granted Jul 11, 2017·0 cites·6 claims
- 2245US2023134760A1Car and nrf2 dual activator agents for cyclophosphamide-based and doxorubicin-based treatments of cancerWANG HONGBING·Filed 2021·Application pending·0 cites
- 2343US2023227476A1Gallium-salophen antimicrobial compounds and methods of use thereofXUE FENGTIAN·Filed 2021·Application pending·0 cites
- 2443US2022041627A1Prodrugs of anti-cancer and anti-autoimmune diseases therapeutic agents, and methods of making and use thereofUNIV MARYLAND·Filed 2019·Application pending·0 cites
- 2542US11701345B2Car activator agents for cyclophosphamide-based treatments of cancerUNIV MARYLAND·Filed 2018·Granted Jul 18, 2023·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Fengtian Xue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →